Association between preoperative glucocorticoids and long-term survival and cancer recurrence after colectomy: Follow-up analysis of a previous randomized controlled trial

British Journal of Anaesthesia

Volumn 113, Issue SUPPL. 1, 2014, Pages

  Singh, P P ^a   Lemanu, D P ^a   Taylor, M H G ^b   Hill, A G ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b MIDDLEMORE HOSPITAL   (New Zealand)

Author keywords

colectomy; colonic neoplasms; dexamethasone; neoplasm metastasis; recurrence

Indexed keywords

DEXAMETHASONE SODIUM PHOSPHATE; PLACEBO;

ABDOMINAL ABSCESS; ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; COLON ADENOCARCINOMA; COLON CANCER; COLON RESECTION; DISEASE FREE SURVIVAL; DOUBLE BLIND PROCEDURE; ELECTIVE SURGERY; FEMALE; FOLLOW UP; HUMAN; ILEUS; LONG TERM SURVIVAL; MALE; METASTATIC MELANOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT DISEASE; SAMPLE SIZE; SINGLE DRUG DOSE; URINARY TRACT INFECTION; URINE RETENTION; VERY ELDERLY; WOUND COMPLICATION;

COLECTOMY; COLONIC NEOPLASMS; DEXAMETHASONE; NEOPLASM METASTASIS; RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; COLECTOMY; COLONIC NEOPLASMS; DEXAMETHASONE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREANESTHETIC MEDICATION;

EID: 84905009321     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aet577     Document Type: Article

References (45)

1. Bovill JG. Surgery for cancer: does anesthesia matter? Anesth Analg 2010; 110: 1524-6
2. Gottschalk A, Sharma S, Ford J, Durieux ME, Tiouririne M. The role of the perioperative period in recurrence after cancer surgery. Anesth Analg 2010; 110: 1636-43
3. Heaney A, Buggy DJ. Can anaesthetic and analgesic techniques affect cancer recurrence or metastasis? Br J Anaesth 2012; 109 (Suppl. 1): i17-28
4. Sessler DI. Long-term consequences of anesthetic management. Anesthesiology 2009; 111: 1-4
5. Snyder GL, Greenberg S. Effect of anaesthetic technique and other perioperative factors on cancer recurrence. Br J Anaesth 2010; 105: 106-15
6. Ben-Eliyahu S, Page GG, Yirmiya R, Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer 1999; 80: 880-8
7. Shakhar G, Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann Surg Oncol 2003; 10: 972-92
8. Tsuchiya Y, Sawada S, Yoshioka I, et al. Increased surgicalstress promotes tumor metastasis. Surgery 2003; 133: 547-55
9. Van der Bij GJ, Oosterling SJ, Beelen RH, Meijer S, Coffey JC, van Egmond M. The perioperative period is an underutilized window of therapeutic opportunity in patients with colorectal cancer. Ann Surg 2009; 249: 727-34
10. Gan TJ, Meyer TA, Apfel CC, et al. Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2007; 105: 1615-28
11. Henzi I, Walder B, Tramer MR. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 2000; 90: 186-94
12. Holte K, Kehlet H. Perioperative single-doseglucocorticoid administration: pathophysiologic effects and clinical implications. J Am Coll Surg 2002; 195: 694-712
13. Lemanu D, Srinivasa S, Singh P, Kahokehr A, Zargar-Shoshtari K, Hill AG. Propensity score analysis evaluating preoperative gluco-corticoid administration in elective colectomy. Int J Surg 2012; 10: 607-10
14. Srinivasa S, Kahokehr AA, Yu TC, Hill AG. Preoperative glucocorticoid use in major abdominal surgery: systematic review and meta-analysis of randomized trials. Ann Surg 2011; 254: 183-91
15. Tasch MD. Corticosteroids and anesthesia. Curr Opin Anaesthesiol 2002; 15: 377-81
16. Deguchi M, Isobe Y, Matsukawa S, Yamaguchi A, Nakagawara G. Usefulnessof metyrapone treatment to suppress cancer metastasis facilitated by surgical stress. Surgery 1998; 123: 440-9
17. Gundisch S, Boeckeler E, Behrends U, Amtmann E, Ehrhardt H, Jeremias I. Glucocorticoids augment survival and proliferation of tumor cells. Anticancer Res 2012; 32: 4251-61
18. Kodama M, Kodama T. Enhancing effect of hydrocortisone on hematogenous metastasis of Ehrlich ascites tumor in mice. Cancer Res 1975; 35: 1015-21
19. Kodama M, Kodama T, Nishi Y, Totani R. Does surgical stress cause tumor metastasis? Anticancer Res 1992; 12: 1603-16
20. Zhang C, Kolb A, Mattern J, et al. Dexamethasone desensitizes hepatocellular and colorectal tumours toward cytotoxic therapy. Cancer Lett 2006; 242: 104-11
21. Keith BD. Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy. BMC Cancer 2008; 8: 84
22. Ostenfeld EB, Erichsen R, Thorlacius-Ussing O, Riis AH, Sørensen HT. Use of systemic glucocorticoids and the risk of colorectal cancer. Aliment Pharmacol Ther 2013; 37: 146-52
23. Rutz HP. Effectsofcorticosteroid useontreatmentofsolid tumours. Lancet 2002; 360: 1969-70
24. Zargar-Shoshtari K, Sammour T, Kahokehr A, Connolly AB, Hill AG. Randomized clinical trialofthe effectofglucocorticoidson peritoneal inflammation and postoperative recovery after colectomy. Br J Surg 2009; 96: 1253-61
25. Zargar-Shoshtari K, Connolly AB, Israel LH, Hill AG. Fast-track surgery may reduce complications following major colonic surgery. Dis Colon Rectum 2008; 51: 1633-40
26. Tekkis PP, Prytherch DR, Kocher HM, et al. Development of a dedicated risk-adjustment scoring system for colorectal surgery (colo-rectal POSSUM). Br J Surg 2004; 91: 1174-82
27. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009; 250: 187-96
28. Greif R, Akca O, Horn EP, Kurz A, Sessler DI, Outcomes Research G. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. N Engl J Med 2000; 342: 161-7
29. Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hos-pitalization. Study of Wound Infection and Temperature Group. N Engl J Med 1996; 334: 1209-15
30. Gottschalk A, Ford JG, Regelin CC, et al. Association between epi-dural analgesia and cancer recurrence after colorectal cancer surgery. Anesthesiology 2010; 113: 27-34
31. Gupta A, Bjornsson A, Fredriksson M, Hallbook O, Eintrei C. Reduction in mortality after epidural anaesthesia and analgesia in patients undergoing rectal but not colonic cancer surgery: a retrospective analysis of data from 655 patients in central Sweden. Br J Anaesth 2011; 107: 164-70
32. Christopherson R, James KE, Tableman M, Marshall P, Johnson FE. Long-term survival after colon cancer surgery: a variation associated with choice of anesthesia. Anesth Analg 2008; 107: 325-32
33. Myles PS, Peyton P, Silbert B, et al. Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: randomised trial. Br Med J 2011; 342: d1491
34. Herr I, Pfitzenmaier J. Glucocorticoid use in prostate cancer and other solid tumours: implications for effectiveness of cytotoxic treatment and metastases. Lancet Oncol 2006; 7: 425-30
35. Holbrook NJ, Cox WI, Horner HC. Direct suppression of natural killer activity in human peripheral blood leukocyte cultures by glucocor-ticoids and its modulation by interferon. Cancer Res 1983; 43: 4019-25
36. Krukowski K, Eddy J, Kosik KL, Konley T, Janusek LW, Mathews HL. Glucocorticoid dysregulation of natural killer cell function through epigenetic modification. Brain Behav Immun 2011; 25: 239-49
37. Onsrud M, Thorsby E. Influence of in vivo hydrocortisone on some human blood lymphocyte subpopulations. I. Effect on natural killer cell activity. Scand J Immunol 1981; 13: 573-9
38. Shakhar G, Blumenfeld B. Glucocorticoid involvement in suppression of NK activity following surgery in rats. J Neuroimmunol 2003; 138: 83-91
39. Ogawa K, Hirai M, Katsube T, et al. Suppression of cellular immunity by surgical stress. Surgery 2000; 127: 329-36
40. De Oliveira GS Jr, Castro-Alves LJ, Ahmad S, Kendall MC, McCarthy RJ. Dexamethasone to prevent postoperative nausea and vomiting: anupdated meta-analysisofrandomized controlled trials. Anesth Analg 2013; 116: 58-74
41. Bolac CS, Wallace AH, Broadwater G, Havrilesky LJ, Habib AS. The impact of postoperative nausea and vomiting prophylaxis with dexamethasoneonpostoperativewoundcomplicationsinpatients undergoing laparotomy for endometrial cancer. Anesth Analg 2013; 116: 1041-7
42. Corcoran TB, Truyens EB, Ng A, Moseley N, Doyle AC, Margetts L. Anti-emetic dexamethasone and postoperative infection risk: a retrospective cohort study. Anaesth Intensive Care 2010; 38: 654-60
43. Eberhart LH, Holdorf S, Albert US, et al. Impact of a single periopera-tive dose of dexamethasone on the incidence of surgical site infec-tions: acase-control study. J Obstet Gynaecol Res 2011;37: 1807-12
44. Waldron NH, Jones CA, Gan TJ, Allen TK, Habib AS. Impact of peri-operative dexamethasone on postoperative analgesia and side-effects: systematic review and meta-analysis. Br J Anaesth 2013; 110: 191-200
45. Percival VG, Riddell J, Corcoran TB. Single dose dexamethasone for postoperative nausea and vomiting-a matched case-control study of postoperative infection risk. Anaesth Intensive Care 2010; 38: 661-6